Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

COMPUGROUP MEDICAL SE & CO. KGAA

(COP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

CompuGroup Medical : Conference Call Presentation

08/05/2021 | 01:36am EST

Q2|2021

Investor/Analyst Call

Dr. Dirk Wössner, CEO

Michael Rauch, CFO

August 5, 2021

Disclaimer

The information provided in this presentation pertaining to CompuGroup Medical SE & Co. KGaA (the "Company"), comprise the written materials/slides for presentations or discussions on the occasion of an investor conference, meeting or conference call ("Meeting"). Whilst all reasonable care has been taken to ensure that the information and facts stated herein as well as oral statements made in the Meeting are accurate and that the opinions and expectations contained herein and orally received during the Meeting are fair and reasonable, no representation or warranty, express or implied, is given by or on behalf of the Company, any of its board members, or any other person as to the accuracy or completeness of the information and/or opinions and no liability as to the accuracy of such information and/or opinions is accepted. The information provided in this presentation as well as during the Meeting contain forward looking statements which involve risks and uncertainties. These forward-looking statements speak only as of the date of the documents and are based on numerous assumptions which may or may not prove to be correct. The actual performance and results of the business of the Company could differ materially from the performance and results discussed in this document or in any other information received during the Meeting. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements or other information contained herein or received during the Meeting whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Readers are cautioned not to place undue reliance on forward-looking statements or financial projections. The information contained in this presentation and/or received during the Meeting does not constitute or form any part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any shares in the Company, nor shall it or any part of it nor the fact of its distribution form the basis of, or be relied on in connection with, any contract or investment decision in relation thereto.

2

August 5, 2021

Q2/21 Investor & Analyst Call

GROUP

OVERVIEW

DR. DIRK WÖSSNER, CEO

3

CompuGroup Medical - A major beneficiary of digitization in healthcare

Digitization

& Interoperability

along the patient journey

while protecting

medical data and infrastructure

4

August 5, 2021

Q2/21 Investor & Analyst Call

CGM fully on track after strong Q2, FY 2021 guidance confirmed

Q2

€241m

67%

+10%

€51m

21%

€0.43

-€6m

(+34%yoy)

(-2ppt)

(+16ppt)

(+14%yoy)

(-4ppt)

(PY: €0.38)

(PY: -€3m)

H1

€470m

68%

+7%

€98m

21%

€0.76

€65m

(+29%yoy)

(+0ppt)

(+9ppt)

(+11%yoy)

(-3ppt)

(PY: €0.72)

(PY: €48m)

Revenue

Recurring

Organic

Adj.

Margin

Adj. EPS

FCF

rev share

growth

EBITDA

5

August 5, 2021

Q2/21 Investor & Analyst Call

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

CompuGroup Medical SE published this content on 05 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 August 2021 05:35:05 UTC.


ę Publicnow 2021
All news about COMPUGROUP MEDICAL SE & CO. KGAA
12/06COMPUGROUP MEDICAL SE & CO. KGAA : Share Buy-Back Program - 1st Interim Announcement
EQ
11/25CompuGroup Medical To Launch $42 Million Share Buyback
MT
11/25COMPUGROUP MEDICAL SE & CO. KGAA : Release of a capital market information
EQ
11/25CompuGroup Medical SE & Co. KGaA adopts resolution on share buy-back program for up to ..
EQ
11/11COMPUGROUP MEDICAL : Gets a Buy rating from Berenberg
MD
11/09COMPUGROUP MEDICAL : Baader Bank remains a Sell rating
MD
11/08COMPUGROUP MEDICAL : Kepler Cheuvreux gives a Neutral rating
MD
11/04CompuGroup Medical SE & Co. KGaA Reports Earnings Results for the Third Quarter and Nin..
CI
11/04COMPUGROUP MEDICAL : Kepler Cheuvreux remains Neutral
MD
11/04COMPUGROUP MEDICAL : Gets a Buy rating from Warburg Research
MD
More news
Analyst Recommendations on COMPUGROUP MEDICAL SE & CO. KGAA
More recommendations
Financials
Sales 2021 1 022 M 1 153 M 1 153 M
Net income 2021 80,6 M 90,9 M 90,9 M
Net Debt 2021 512 M 577 M 577 M
P/E ratio 2021 45,2x
Yield 2021 0,83%
Capitalization 3 594 M 4 040 M 4 053 M
EV / Sales 2021 4,02x
EV / Sales 2022 3,73x
Nbr of Employees 8 079
Free-Float 48,8%
Chart COMPUGROUP MEDICAL SE & CO. KGAA
Duration : Period :
CompuGroup Medical SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COMPUGROUP MEDICAL SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 68,15 €
Average target price 84,80 €
Spread / Average Target 24,4%
EPS Revisions
Managers and Directors
Dirk W÷ssner Chairman-Management Board & CEO
Philipp von Ilberg Chairman-Supervisory Board
Frank Brecher Chief Technology Officer
Sven Thomas MŘller Vice Chairman & Chief Information Officer
Ulrike Handel Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
COMPUGROUP MEDICAL SE & CO. KGAA-13.30%3 881
ORACLE CORPORATION37.49%243 134
SAP SE8.47%154 714
SERVICENOW, INC.12.01%122 688
CONSTELLATION SOFTWARE INC.32.42%36 281
HUBSPOT, INC.93.13%33 661